Table 1.
Baseline characteristics | Treatment group | ||
---|---|---|---|
ASMQ + Pq | CQ + Pq | AL + Pq | |
N (%) | 88 (33.3%) | 88 (33.3%) | 88 (33.3%) |
Study site | |||
CEPEM | 66 (75.0%) | 66 (75.0%) | 66 (75.0%) |
FMT-HVD | 22 (25.0%) | 22 (25.0%) | 22 (25.0%) |
Gender | |||
Female | 32 (36.4%) | 22 (25.0%) | 24 (27.3%) |
Male | 56 (63.6%) | 66 (75.0%) | 64 (72.7%) |
Age (years) | |||
> 59 | 3 (3.4%) | 4 (4.5%) | 3 (3.4%) |
18–39 | 45 (51.1%) | 34 (38.6%) | 49 (55.7%) |
39–59 | 40 (45.4%) | 50 (56.8%) | 36 (40.9%) |
Weight (kg) | |||
> 80 | 25 (28.4%) | 22 (25.0%) | 27 (30.7%) |
50–65 | 27 (30.7%) | 21 (23.9%) | 23 (26.1%) |
65–80 | 36 (40.9%) | 45 (51.1%) | 38 (43.2%) |
Fever | |||
< 37.5 | 48 (54.5%) | 54 (61.4%) | 53 (60.2%) |
> 37.5 | 40 (45.4%) | 34 (38.6%) | 35 (39.8%) |
Weight (kg) | 71.59 (10.99) [51–90] |
72.7 (10.34) [53–90] |
72.53 (10.59) [50–90] |
Temperature | 37.45 (1.38) [34.7–40.5] |
37.31 (1.21) [35.0–39.9] |
37.38 (1.22) [35.2–40.6] |
Parasitaemia | 2145 (2516.4) [258–13,340] |
2155 (2908.5) [285–17,680] |
2444 (3974.6) [270–20,080] |
Age (years) | 38.75 (10.9) [19.5–65.8] |
41.88 (10.5) [19.7–64.9] |
37.24 (11.8) [18.4–64.3] |
Absolute number and percentage (%) were used to present categorical variables. Quantitative data presented using means, standard deviations (SD), and ranges [min–max]. Parasitaemia presented using geometric mean